The News Review:
- AIIMS-like Ayurveda institute to come up in Delhi
- AIDS vaccine: Chennai trial results encouraging
- St. Jude Medical Announces First Enrollment in Study To Understand…
AIIMS-like Ayurveda institute to come up in Delhi
Times of India – Jan 24, 2008
A meeting of theUnion Cabinet chaired by Prime Minister Manmohan Singh approved theestablishment of the All India Institute of Ayurveda (AIIA) as an autonomousorganisation under the Department ofAYUSH. The Cabinet also gaveits nod to appoint a Director with supporting staff to oversee projectimplementation Information and Broadcasting Minister P R Dasmunsi toldreporters in New Delhi. An11-acre plot in Sarita Vihar in south Delhi has been identified for setting upthe AIIA which will also have a 200 bed research and referral hospital forfacilitating clinicalresearch. The institute willinitially be set up as an autonomous registered body of the Ministry of Healthand Family Welfare and will be fully funded by the Central government with theobjective of raising it to the status of Deemed University in 10years.
AIDS vaccine: Chennai trial results encouraging
Hindu – Jan 24, 2008
Patricia Fast Executive Director (Medical Affairs) of the International AIDS Vaccine Initiative New York in an email communication to this Correspondent noted “…We expect that the [interim data result] is close to the final responses. ” nly Phase II and Phase III trials involving larger number of people would help in knowing this crucial issue. “The results of the first trial suggest that further clinical research is warranted” Dr. She also indicated that the conduct of further clinical research will depend on the Indian Government. The man behind If the MVA vaccine has shown encouraging results in the Phase I trial the full credit should go to the person who was responsible for producing the MVA vaccine construct — Dr. Sekar Chakraborty Deputy Director of the National Institute of Cholera and Enteric Diseases Kolkata… “The results of the first trial suggest that further clinical research is warranted” Dr. She also indicated that the conduct of further clinical research will depend on the Indian Government. The man behind If the MVA vaccine has shown encouraging results in the Phase I trial the full credit should go to the person who was responsible for producing the MVA vaccine construct — Dr. Sekar Chakraborty Deputy Director of the National Institute of Cholera and Enteric Diseases Kolkata. Unlike the vaccine tested in Pune (AAV) that contained only three HIV genes put into the vector the MVA has six genes. But it is not just the number of genes that has probably resulted in better immune responses.
St. Jude Medical Announces First Enrollment in Study To Understand…
Business Wire – Business Wire (press release) – Jan 24, 2008
Jude Medical previously supported the GELIA (German Experience with Low Intensity Anticoagulation) and ESCAT (Early Self-Controlled Anticoagulation Trial) studies. These studies collected data from thousands of patients in European centers and provided evidence on anti-coagulation treatments following implantation of mechanical heart valves. The DCRI is the world’s largest academic clinical research organization combining clinical expertise academic leadership and the full-service operational capabilities of a contract research organization. With 950 faculty and staff the DCRI’s experience includes Phase I through Phase IV clinical trials post-market analyses and health economics. Jude Medical St. Jude Medical is dedicated to making life better for cardiac neurological and chronic pain patients worldwide through excellence in medical device technology and services.
